Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy PLx Pharma stock | $5.46

Own PLx Pharma stock in just a few minutes.

Fact checked

PLx Pharma Inc is a drug manufacturers-specialty & generic business based in the US. PLx Pharma shares (PLXP) are listed on the NASDAQ and all prices are listed in US Dollars. PLx Pharma employs 10 staff and has a trailing 12-month revenue of around USD$54,323.

How to buy shares in PLx Pharma

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for PLx Pharma. Find the stock by name or ticker symbol: PLXP. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until PLx Pharma reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$5.46, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of PLx Pharma, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of PLx Pharma. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

PLx Pharma share price

Use our graph to track the performance of PLXP stocks over time.

PLx Pharma shares at a glance

Information last updated 2020-12-09.
Latest market closeUSD$5.46
52-week rangeUSD$1.8 - USD$6.42
50-day moving average USD$4.2657
200-day moving average USD$3.6033
Wall St. target priceUSD$9
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-3.868

Buy PLx Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy PLx Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PLx Pharma price performance over time

Historical closes compared with the close of $5.46 from 2020-12-09

1 week (2021-01-09) N/A
1 month (2020-12-16) 3.61%
3 months (2020-10-16) N/A
6 months (2020-07-16) N/A
1 year (2020-01-16) N/A
2 years (2019-01-16) N/A
3 years (2018-01-16) N/A
5 years (2016-01-16) N/A

PLx Pharma financials

Revenue TTM USD$54,323
Gross profit TTM USD$565,464
Return on assets TTM -46.52%
Return on equity TTM -226.65%
Profit margin 0%
Book value $-1.504
Market capitalisation USD$50 million

TTM: trailing 12 months

Shorting PLx Pharma shares

There are currently 140,029 PLx Pharma shares held short by investors – that's known as PLx Pharma's "short interest". This figure is 1% up from 138,574 last month.

There are a few different ways that this level of interest in shorting PLx Pharma shares can be evaluated.

PLx Pharma's "short interest ratio" (SIR)

PLx Pharma's "short interest ratio" (SIR) is the quantity of PLx Pharma shares currently shorted divided by the average quantity of PLx Pharma shares traded daily (recently around 12491.436217663). PLx Pharma's SIR currently stands at 11.21. In other words for every 100,000 PLx Pharma shares traded daily on the market, roughly 11210 shares are currently held short.

However PLx Pharma's short interest can also be evaluated against the total number of PLx Pharma shares, or, against the total number of tradable PLx Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PLx Pharma's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 PLx Pharma shares in existence, roughly 20 shares are currently held short) or 0.0188% of the tradable shares (for every 100,000 tradable PLx Pharma shares, roughly 19 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against PLx Pharma.

Find out more about how you can short PLx Pharma stock.

PLx Pharma share dividends

We're not expecting PLx Pharma to pay a dividend over the next 12 months.

Have PLx Pharma's shares ever split?

PLx Pharma's shares were split on a 1:8 basis on 20 April 2017. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PLx Pharma shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for PLx Pharma shares which in turn could have impacted PLx Pharma's share price.

PLx Pharma share price volatility

Over the last 12 months, PLx Pharma's shares have ranged in value from as little as $1.8 up to $6.42. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PLx Pharma's is 5.1954. This would suggest that PLx Pharma's shares are significantly more volatile than the average for this exchange and represent a higher risk.

PLx Pharma overview

PLx Pharma Inc., a late-stage specialty pharmaceutical company, focuses on developing the PLxGuard delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system to reduce novel gastrointestinal (GI) side effects while providing antiplatelet effectiveness for cardiovascular disease prevention and treatment. Its product pipeline also includes other oral nonsteroidal anti-inflammatory drugs using the PLxGuard delivery system, such as PL1200 Ibuprofen 200 mg, a GI-safer ibuprofen product for pain and inflammation, as well as PL1100 Ibuprofen 400 mg. PLx Pharma Inc. was founded in 2002 and is headquartered in Sparta, New Jersey.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site